Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment.

Shibata A, McMullen E, Pham A, Belshan M, Sanford B, Zhou Y, Goede M, Date AA, Date AA, Destache CJ. Polymeric nanoparticles containing combination antiretroviral drugs for HIV type 1 treatment. AIDS Res Hum Retroviruses. 2013 May; 29(5):746-54.

View in: PubMed

subject areas

Alkynes
Anti-HIV Agents
Benzoxazines
CD4-Positive T-Lymphocytes
Cell Line
Cell Survival
Cyclopropanes
Drug Therapy, Combination
Hela Cells
HIV Infections
HIV-1
Humans
Lactic Acid
Microscopy, Confocal
Nanoparticles
Polyglycolic Acid
Subcellular Fractions
U937 Cells

authors with profiles

Abhijit Date, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support